| Life Technologies sells majority share in mass spectrometry business | Posted on 03/09/2009 in Scientific Life Technologies has signed a contract to sell the controlling stake of its mass spectrometry arm to Danaher for a total of $450 million (276 million pounds), it has revealed.
Previously operated jointly, the business will now be owned by Danaher, which has also revealed that it has acquired Life Technologies' partner firm MDS Analytical Technologies - a division of MDS.
All transactions are anticipated to be completed by the final financial quarter of 2009.
Greg Lucier, chairman and chief executive of Life Technologies, stated that the sale of the mass spectrometry arm will allow the firm to shift its focus to its core capabilities.
He added: "By concentrating on biological solutions that leverage our expertise in DNA, RNA, proteins and cells, we will continue to drive breakthroughs in life science research, genomic medicine, molecular diagnostics and applied markets."
In other Life Technologies news, the company announced early in August that it had completed the sale of its SQL*LIMS business arm to Labvantage Solutions, but did not disclose a sum.  Other news stories from 03/09/2009
Read more in the Zenopa News Archive
How this news is generated
|  |
|
